TickerFactsScreenerDevelopers

Spyre Therapeutics, Inc. (SYRE) — Total Assets

Annual figures by fiscal year, from SEC filings.

2015: $38.65M2016: $67.06M2017: $56.08M2018: $77.74M2019: $83.18M2020: $161.62M2021: $109.93M2022: $71.14M2023: $341.86M2024: $608.48M2025: $777.78M$777.78M
2015Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$777.78M+27.8%
2024$608.48M+78.0%
2023$341.86M+380.5%
2022$71.14M-35.3%
2021$109.93M-32.0%
2020$161.62M+94.3%
2019$83.18M+7.0%
2018$77.74M+38.6%
2017$56.08M-16.4%
2016$67.06M+73.5%
2015$38.65M—